Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bladder Preservation for MIBC With Variant Histology
NCT06417190Phase 2Recruiting
- Start
- Jan 2026
- Primary completion
- Dec 2030
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in bladder carcinoma. Primary endpoint: Feasibility of initiating TMT at 45 days. Started Jan 2026; status: recruiting.
02
Conditions
bladder carcinoma
Beyond the preview
Go deeper on NCT06417190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06417190.